Joshua Bleharski - 27 Jun 2025 Form 3 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Chief Financial Officer
Signature
/s/ Andres Ruiz Briseno, as Attorney-in-Fact for Joshua Bleharski
Issuer symbol
IDYA
Transactions as of
27 Jun 2025
Net transactions value
$0
Form type
3
Filing time
27 Jun 2025, 16:20:15 UTC
Next filing
02 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bleharski Joshua Chief Financial Officer C/O IDEAYA BIOSCIENCES, INC., 5000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO /s/ Andres Ruiz Briseno, as Attorney-in-Fact for Joshua Bleharski 27 Jun 2025 0002075052

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IDYA Stock Option (right to buy) 27 Jun 2025 Common Stock 250,000 $20.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from May 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Exhibit 24.1 - Power of Attorney